by admin | Jul 11, 2018 | Company News
Vilacto Bio Focuses Resources On Pharmaceutical Opportunities for LACTOACTIVE iTHER® Press Release | 07/11/2018 COPENHAGEN, Denmark, July 11, 2018 (GLOBE NEWSWIRE) — Vilacto Bio Inc. (OTCQB:VIBI) plans to focus on its new pharmaceutical product, LACTOACTIVE...
by admin | Jun 14, 2018 | Company News
Vilacto Bio’s Vilact Skin Cream Wins Award at Las Vegas ECRM Skin, Bath, Cosmetics & Natural Beauty EPPS COPENHAGEN, Denmark, June 14, 2018 (GLOBE NEWSWIRE) — Vilacto Bio Inc.’s (OTCQB:VIBI) Vilact skin cream won the buyers choice award at the recent ECRM...
by admin | May 23, 2018 | Company News
Vilacto Bio Inc. Upgrades Denmark Plant; Paves Way for New LACTOACTIVE iTHER® to Stimulate Local Antibody ProductionPress Release | 05/23/2018 COPENHAGEN, Denmark, May 23, 2018 — Vilacto Bio Inc. (OTC QB:VIBI) has completed a two-month upgrade to the Denmark...
by admin | Jan 18, 2018 | Company News, Uncategorized
Vilacto Bio Inc. Begins Development of the Vilacto Bio Skincare Knowledge Center Jan 18, 2018 OTC Disclosure & News Service COPENHAGEN, Denmark, Jan. 18, 2018 (GLOBE NEWSWIRE) — Vilacto Bio Inc. (OTCQB:VIBI), today announced that it has commenced...
by admin | Nov 30, 2017 | Company News, Uncategorized
Vilacto Bio, Inc. Issues Statement About Promotional Activity Concerning Its Common Stock Nov 30, 2017 OTC Disclosure & News Service – COPENHAGEN, Denmark, Nov. 30, 2017 (GLOBE NEWSWIRE) — Vilacto Bio, Inc. the “Company” (OTCQB:VIBI), today announced...
by admin | Nov 22, 2017 | Company News, Uncategorized
Vilacto Bio Inc. speeds up cooperation with Pharma GP to reach higher targets Nov 22, 2017 OTC Disclosure & News Service COPENHAGEN, Denmark, Nov. 22, 2017 (GLOBE NEWSWIRE) — Vilacto Bio Inc. (OTC QB:VIBI), is pleased to announce that within the next 3...
